|
FAM111A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62747593179802E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.99200722162641E-16 |
| Normal-vs-Stage2 |
6.572100E-02 |
| Normal-vs-Stage3 |
5.628600000529E-07 |
| Normal-vs-Stage4 |
7.08680000238715E-08 |
| Stage1-vs-Stage2 |
4.475500E-03 |
| Stage1-vs-Stage3 |
1.331780E-02 |
| Stage1-vs-Stage4 |
9.728400E-01 |
| Stage2-vs-Stage3 |
1.512370E-01 |
| Stage2-vs-Stage4 |
9.737200E-03 |
| Stage3-vs-Stage4 |
6.336400E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62525548574877E-12 |
| Normal-vs-AfricanAmerican |
1.001710E-02 |
| Normal-vs-Asian |
2.14599449321895E-11 |
| Caucasian-vs-AfricanAmerican |
4.227200E-01 |
| Caucasian-vs-Asian |
1.092650E-01 |
| AfricanAmerican-vs-Asian |
7.365900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.503700051257E-09 |
| Normal-vs-Female |
1.33226762955019E-14 |
| Male-vs-Female |
6.053000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.626032641866E-12 |
| Normal-vs-Age(41-60Yrs) |
2.8030910925736E-12 |
| Normal-vs-Age(61-80Yrs) |
4.642500E-03 |
| Normal-vs-Age(81-100Yrs) |
5.019400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.254000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.04100000000107E-05 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.220200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.498600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.053800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.928400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.790000E-02 |
| Classical-VS-Follicular |
2.05391259555654E-14 |
| Classical-VS-Other |
5.274800E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
2.02299999999545E-05 |
| Tall-VS-Other |
9.004000E-01 |
| Tall-VS-Normal |
1.43389999995858E-06 |
| Follicular-VS-Other |
4.952300E-02 |
| Follicular-VS-Normal |
9.193000E-01 |
| Other-VS-Normal |
6.394300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.48399999750404E-08 |
| Normal-vs-N1 |
1.48790000320531E-08 |
| N0-vs-N1 |
7.819900E-03 |
|
|
